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To Push or Not to Push? Use of IV Dextrose vs. Oral Dex4 for Treatment of Hypoglycemia.
Background:
• Within the network, there have been a number of adverse events 
in which patients have needed to go into surgery after 
extravasation of IV D50.  
• There is currently a national shortage of IV dextrose.
• IV D50 is $6.58-$7.77 per administration versus oral dextrose 
which costs $1.29 (more cost effective to give oral Dex4).
• Staff nurses found to be administering IV D50 despite physician 
order parameters to only give if unable to administer oral 
treatment.
•Evidence:
• IV dextrose is considered a vesicant drug if the concentration is ≥ 
10%
• Risk of extravasation and permanent nerve and tissue injury if IV 
D50 is administered peripherally (Lawson, Brady, & Mahmoud, 
2013).
• Oral liquid/gel dextrose is first line therapy for the patient who is 
able to safely swallow and is not NPO (AACE, 2014).
• Reserve IV D50 only for the patient unable to safely swallow or 
is NPO (AACE, 2014).
• When medication is not given per the physician order (given IV 
when the patient is not NPO and can swallow), it is considered 
working outside nursing scope of practice (PA State Board of 
Nursing, 2000).
• Retrieved data from RL Solutions Patient Safety reporting 
regarding 20 episodes of hypoglycemia before the start date 
of the project (December 4th). Baseline unit compliance with 
using correct treatment was compiled using the review 
notation of the LVHN Inpatient Diabetes  Education Manager, 
who investigates all episodes of severe hypoglycemia.
• A pre-survey was administered to 20 staff nurses to assess 
knowledge regarding oral versus IV dextrose treatment for 
hypoglycemia
• A power point education outlining which treatment is 
indicated for hypoglycemia was created to educate staff 
nurses. The education included input from the Inpatient 
Diabetes Education Manager as the subject matter expert.    
Electronic communication was sent to staff requesting review 
of education by 12/18/17.
• Education placed in break room with a roster.  Staff nurses 
reviewed power point and signed roster once finished.  
Education reviewed by 18 nurses.
• Data was retrieved using same methods for 20 episodes of 
hypoglycemia starting 12/18/17.  Compliance with indicated 
treatment was compared from before and after the education 









# 0f times Dex 4 was used
# of times IV dextrose was used
• Will educating Registered Nurses on the proper use and 
administration of hypoglycemic agents increase the 
compliance of administering the  appropriate hypoglycemic 
agent at the time needed?
– P: Medical-surgical registered nurses
– I: Educating Registered Nurses on the appropriate 
treatment of hypoglycemic events
– C: Administering oral glucose versus intravenous 
dextrose
– O: Increased compliance with administration of the 
appropriate hypoglycemic treatment
• Compared to pre-education data, the number of hypoglycemic 
events with inappropriate treatment  decreased 62.5% after RN 
education completed.
• Barriers – It was noted that nurses were more likely to want to 
give IV D50 for severe hypoglycemia (<40) even if the patient 
was able to safely swallow – possibly because of the emergent 
nature of the hypoglycemia.
• Next steps – LVHN Diabetes Quality Improvement Team is 
working in conjunction with pharmacy to reinforcement 
appropriate treatment using an electronic “pop-up” notification in 
the Pyxis machine to prompt nursing into making the proper 
medication selection.  This project was initiated shortly before 
this network wide initiative was implemented on 1/22/18.
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